Drug Profile
GSI 136
Alternative Names: GSI-136Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antidementias
- Mechanism of Action Amyloid precursor protein secretase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 31 May 2009 Discontinued - Phase-I for Alzheimer's disease in Japan (PO)
- 31 May 2009 Discontinued - Phase-I for Alzheimer's disease in USA (PO)
- 31 Mar 2008 Phase-I clinical trials in Alzheimer's disease in Japan (PO)